Industry Pfizer will likely walk away from AstraZeneca: analyst Add to ...

SHARE

Replay
Reuters |
Show Description
Joe Rundle, head of trading at ETX Capital, says the pharmaceutical giant probably won't take its bid hostile

More from this section

Most Popular

Editor's Picks

Globe Shows »

Careers
Put your best foot forward with our expert advice